Multiple studies on cerebral ischemia have been performed in animal models to propose different strategies of neuroprotection that mitigate either the early or late consequences of the disease. These therapies have been successful in reducing the volume of infarction, the proinflammatory cascade, and the amount of free radicals, as well as reversing markers of neurodegeneration, among other events. However, when those strategies are translated to clinical studies, their effectiveness is not reproduced.
from Journal of the Neurological Sciences https://ift.tt/2BKdI3h
from Journal of the Neurological Sciences https://ift.tt/2BKdI3h
Comments
Post a Comment